| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |